title: Interventional management of atrial fibrillation.
abstract: Atrial fibrillation (AF) is the most common arrhythmia seen in clinical practice, and is associated with increased morbidity and mortality. Management of AF is challenging due to the modest efficacy of antiarrhythmic drug therapies, some of which have significant adverse effects or toxicity. Nonpharmacological treatment of AF, including AF ablation, has recently evolved as an attractive, efficacious and potentially 'curative' therapeutic modality in selected patients. This article reviews various interventional therapeutic options for the management of AF, appropriate patient selection and clinical implications.
authors.affiliation: Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, 5777 E. Mayo Boulevard, Phoenix, AZ 85054, USA.
authors.forename: Sandeep
authors.initials: S
authors.lastname: Arora
authors.forename: Farouk
authors.initials: F
authors.lastname: Mookadam
authors.forename: Komandoor
authors.initials: K
authors.lastname: Srivathsan
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001281:Atrial Fibrillation / Q000503:physiopathology / Q000628:therapy*; D001283:Atrioventricular Node / Q000601:surgery; D002304:Cardiac Pacing, Artificial; D006348:Cardiac Surgical Procedures; D017115:Catheter Ablation / Q000009:adverse effects / Q000379:methods / Q000639:trends; D004334:Drug Administration Schedule; D004554:Electric Countershock; D015716:Electrocardiography, Ambulatory; D005500:Follow-Up Studies; D006801:Humans; D018579:Patient Selection; D011159:Population Surveillance; D018570:Risk Assessment; D013610:Tachycardia / Q000517:prevention & control
chemical_list: D000889:Anti-Arrhythmia Agents